Pekin Hardy Strauss, Inc. Novartis Ag Transaction History

Pekin Hardy Strauss, Inc.

  • $749 Million
  • Q3 2024

A detailed history of Pekin Hardy Strauss, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 38,493 shares of NVS stock, worth $4 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
38,493
Previous 38,818 0.84%
Holding current value
$4 Million
Previous $4.13 Million 7.14%
% of portfolio
0.59%
Previous 0.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $34,492 - $39,289
-325 Reduced 0.84%
38,493 $4.43 Million
Q2 2024

Aug 09, 2024
SELL
$92.57 - $107.37 $106,640 - $123,690
-1,152 Reduced 2.88%
38,818 $4.13 Million
Q1 2024

May 02, 2024
SELL
$95.27 - $108.47 $56,114 - $63,888
-589 Reduced 1.45%
39,970 $3.87 Million
Q4 2023

Feb 05, 2024
SELL
$92.27 - $101.54 $118,566 - $130,478
-1,285 Reduced 3.07%
40,559 $4.1 Million
Q3 2023

Nov 07, 2023
SELL
$94.73 - $105.13 $80,520 - $89,360
-850 Reduced 1.99%
41,844 $4.26 Million
Q2 2023

Aug 08, 2023
SELL
$92.52 - $104.91 $93,260 - $105,749
-1,008 Reduced 2.31%
42,694 $4.31 Million
Q1 2023

May 08, 2023
SELL
$80.03 - $92.81 $2,320 - $2,691
-29 Reduced 0.07%
43,702 $4.02 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $39,361 - $48,202
-521 Reduced 1.18%
43,731 $3.97 Million
Q3 2022

Nov 09, 2022
SELL
$74.61 - $87.26 $67,149 - $78,534
-900 Reduced 1.99%
44,252 $3.36 Million
Q2 2022

Aug 05, 2022
BUY
$80.52 - $93.75 $52,338 - $60,937
650 Added 1.46%
45,152 $3.82 Million
Q1 2022

May 13, 2022
SELL
$80.11 - $90.62 $242,172 - $273,944
-3,023 Reduced 6.36%
44,502 $3.91 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $330,675 - $365,651
-4,149 Reduced 8.03%
47,525 $4.16 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $17,582 - $20,455
-215 Reduced 0.41%
51,674 $4.23 Million
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $232,705 - $257,029
-2,730 Reduced 5.0%
51,889 $4.73 Million
Q1 2021

May 13, 2021
SELL
$83.5 - $98.47 $234,885 - $276,996
-2,813 Reduced 4.9%
54,619 $4.67 Million
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $372,315 - $450,336
-4,769 Reduced 7.67%
57,432 $5.42 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $224,817 - $249,067
-2,737 Reduced 4.21%
62,201 $5.41 Million
Q2 2020

Aug 10, 2020
SELL
$80.93 - $91.1 $135,557 - $152,592
-1,675 Reduced 2.51%
64,938 $5.67 Million
Q1 2020

May 11, 2020
SELL
$70.67 - $99.01 $325,294 - $455,743
-4,603 Reduced 6.46%
66,613 $5.49 Million
Q4 2019

Feb 12, 2020
SELL
$84.35 - $95.37 $221,418 - $250,346
-2,625 Reduced 3.55%
71,216 $6.74 Million
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $304,009 - $335,000
-3,554 Reduced 4.59%
73,841 $6.42 Million
Q2 2019

Aug 12, 2019
SELL
$75.4 - $92.8 $400,675 - $493,139
-5,314 Reduced 6.42%
77,395 $7.07 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $161,636 - $184,877
-2,146 Reduced 2.53%
82,709 $7.95 Million
Q4 2018

Feb 12, 2019
SELL
$73.66 - $82.02 $2.99 Million - $3.32 Million
-40,535 Reduced 32.33%
84,855 $7.28 Million
Q3 2018

Nov 02, 2018
SELL
$66.94 - $77.43 $104,493 - $120,868
-1,561 Reduced 1.23%
125,390 $10.8 Million
Q2 2018

Aug 03, 2018
SELL
$64.91 - $73.36 $153,447 - $173,423
-2,364 Reduced 1.83%
126,951 $9.59 Million
Q1 2018

May 01, 2018
SELL
$70.39 - $84.15 $307,252 - $367,314
-4,365 Reduced 3.27%
129,315 $0
Q4 2017

Feb 02, 2018
SELL
$72.33 - $77.64 $328,450 - $352,563
-4,541 Reduced 3.29%
133,680 $0
Q3 2017

Nov 03, 2017
BUY
$74.14 - $77.27 $10.2 Million - $10.7 Million
138,221
138,221 $11.9 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Pekin Hardy Strauss, Inc. Portfolio

Follow Pekin Hardy Strauss, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email